Systems Pathology for Predicting Risk of Recurrence in Prostate Cancer - Prostate Px Test
ثبت نشده
چکیده
©2014 Blue Cross and Blue Shield of Louisiana An independent licensee of the Blue Cross and Blue Shield Association No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, or otherwise, without permission from Blue Cross and Blue Shield of Louisiana. Page 1 of 7 Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the “Company”), unless otherwise provided in the applicable contract. Medical technology is constantly evolving, and we reserve the right to review and update Medical Policy periodically.
منابع مشابه
Aureon Prostate PxTM Predicting Prostate Cancer Recurrence
Aureon Laboratories is applying its integrative Systems Pathology platform to develop predictive clinical tests for prostate cancer patients. The initial offering is Prostate Px™, a unique prognostic test designed to provide patients and their physicians with more information as they make decisions about treatment options. Prostate Px is able to stratify patients as high or low risk for disease...
متن کاملAssociation between prostate specific antigen change over time and prostate cancer recurrence risk: a joint model
Background: Prostate specific antigen (PSA) is an important biomarker to monitor patients after treated with radiation therapy (RT). The aim of this study is to evaluate the relationship between the PSA data and prostate cancer recurrence using the joint modeling. Methods: This historical cohort study was performed on 422 prostate cancer patients. Inclusion criteria included: patients with loc...
متن کاملبررسی اپیدمیولوژیک نئوپلاسم های پروستات در شهر بیرجند
Background and Aim: Prostate gland is one of the most important exocrine gland in the male genital system, whose neoplasms are very common in Iran and other countries. The incidence of the disease is not the same among different racial communities. Therefore, epidemiologic studies can be useful in our country. This study was aimed to determine the epidemiologic characteristics of prostate neopl...
متن کاملNeoadjuvant chemotherapy in high-risk localized prostate cancer: a systematic review
Background: The rate of recurrence and mortality in high-risk prostate cancer remains high. On the other hand, the use of chemotherapy in metastatic prostate cancer has improved overall survival of patients. The aim of this study was to evaluate the effect of neoadjuvant chemotherapy alone on increasing survival of patients with high risk localized prostate cancer Methods: This is a systematic...
متن کاملComparison of PSA profile with positive prostate cancer pathology and Gleason scores in 2015-2017 in Hamadan
Background and Objective: Prostate cancer is one of the most common cancers of the urinary system. The most used method for diagnosis is transrectal ultrasonography-guided biopsy. The purpose of this study is a statistical analysis with the aim of reducing unnecessary biopsies based on individual, geographical and genetic patterns in our region. Methods: The medical records of all patients who...
متن کامل